Cellebrite DI Ltd. (NASDAQ:CLBT) Stock Holdings Raised by Voss Capital LP

Voss Capital LP raised its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 1.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,240,000 shares of the company's stock after purchasing an additional 39,700 shares during the quarter. Cellebrite DI comprises approximately 5.3% of Voss Capital LP's portfolio, making the stock its 7th largest holding. Voss Capital LP owned about 1.57% of Cellebrite DI worth $71,377,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Juncture Wealth Strategies LLC boosted its holdings in shares of Cellebrite DI by 0.8% in the fourth quarter. Juncture Wealth Strategies LLC now owns 60,003 shares of the company's stock valued at $1,322,000 after acquiring an additional 505 shares in the last quarter. TD Waterhouse Canada Inc. boosted its holdings in Cellebrite DI by 1.8% in the 4th quarter. TD Waterhouse Canada Inc. now owns 47,497 shares of the company's stock valued at $1,046,000 after purchasing an additional 859 shares in the last quarter. Strategic Advisors LLC increased its position in Cellebrite DI by 3.4% during the 4th quarter. Strategic Advisors LLC now owns 29,082 shares of the company's stock worth $641,000 after purchasing an additional 950 shares during the period. Steward Partners Investment Advisory LLC raised its stake in shares of Cellebrite DI by 12.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 13,590 shares of the company's stock worth $299,000 after buying an additional 1,463 shares in the last quarter. Finally, Tower View Wealth Management LLC boosted its stake in shares of Cellebrite DI by 1.3% in the fourth quarter. Tower View Wealth Management LLC now owns 132,307 shares of the company's stock valued at $2,915,000 after buying an additional 1,660 shares in the last quarter. 45.88% of the stock is owned by hedge funds and other institutional investors.

Cellebrite DI Price Performance

Shares of NASDAQ CLBT traded up $0.08 on Friday, hitting $19.64. The company's stock had a trading volume of 468,650 shares, compared to its average volume of 1,411,353. The stock has a 50 day moving average of $18.73 and a 200-day moving average of $20.11. The company has a market capitalization of $4.70 billion, a price-to-earnings ratio of -14.13, a price-to-earnings-growth ratio of 4.27 and a beta of 1.44. Cellebrite DI Ltd. has a 12-month low of $10.25 and a 12-month high of $26.30.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $0.07 EPS for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). Cellebrite DI had a negative net margin of 70.54% and a positive return on equity of 58.70%. Sell-side analysts expect that Cellebrite DI Ltd. will post 0.3 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Needham & Company LLC reissued a "buy" rating and issued a $28.00 target price on shares of Cellebrite DI in a report on Wednesday, April 2nd. Lake Street Capital raised their price objective on shares of Cellebrite DI from $17.00 to $26.00 and gave the company a "buy" rating in a research note on Friday, February 14th. Finally, JPMorgan Chase & Co. upped their target price on shares of Cellebrite DI from $24.00 to $28.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 11th. Seven investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $23.43.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.